IMMUNOPRECISE ANTIBODIES LTD (IPA)
CA45257F2008 - Common Stock
| MRQ (2024-10-31) | 2024 (2024-4-30) | 2023 (2023-4-30) | 2022 (2022-4-30) | 2021 (2021-4-30) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 3.53M | 3.46M | 8.28M | 29.96M | 41.76M | |||
| Marketable Securities | N/A | N/A | N/A | N/A | N/A | |||
| Receivables | 5.30M | 4.48M | 4.42M | 3.41M | 4.12M | |||
| Inventories | 2.01M | 2.14M | 2.06M | 1.61M | 1.20M | |||
| Other Current Assets | 1.66M | 1.41M | 2.04M | 2.48M | 1.78M | |||
| Total Current Assets | 12.50M | 11.49M | 16.79M | 37.47M | 48.86M | |||
| Non-Current Assets | ||||||||
| PPE Net | 15.96M | 16.70M | 10.39M | 3.56M | 4.02M | |||
| Investments And Advances | N/A | 0.00 | 115.00K | 142.00K | 111.00K | |||
| Goodwill | 7.92M | 7.69M | 19.17M | 19.64M | 7.78M | |||
| Intangibles | 23.01M | 23.56M | 30.93M | 32.39M | 6.06M | |||
| Other Non-Current Assets | 577.00K | 561.00K | 418.00K | 451.00K | 131.00K | |||
| Total Non-Current Assets | 47.46M | 48.50M | 61.02M | 56.18M | 18.10M | |||
| TOTAL ASSETS | 59.96M | 59.99M | 77.81M | 93.65M | 66.96M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 3.09M | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 1.66M | 1.56M | 1.12M | 2.30M | 986.00K | |||
| Accrued Expenses | N/A | N/A | 2.00K | 31.00K | 140.00K | |||
| Accounts Payable | 5.38M | 4.37M | 3.39M | 4.77M | 3.01M | |||
| Other Current Liabilities | 2.27M | 2.19M | 1.42M | 2.19M | 1.94M | |||
| Total Current Liabilities | 12.41M | 8.12M | 5.92M | 9.29M | 6.07M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 11.67M | 12.12M | 6.15M | 468.00K | 2.47M | |||
| Deferred Taxes/Income | 3.21M | 5.83M | 7.66M | 8.11M | 1.49M | |||
| Other Non-Current Liabilities | N/A | 0.00 | 278.00K | 497.00K | 0.00 | |||
| Total Non-Current Liabilities | 14.88M | 17.94M | 14.09M | 9.07M | 3.96M | |||
| TOTAL LIABILITIES | 27.29M | 26.07M | 20.01M | 18.36M | 10.04M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -105.11M | -100.27M | -73.09M | -46.53M | -29.82M | |||
| Additional Paid In Capital | 12.71M | 12.39M | 10.80M | 9.63M | 7.20M | |||
| Common Shares | 122.31M | 119.77M | 117.47M | 114.56M | 80.10M | |||
| Other Shareholders' Equity | 2.77M | 2.02M | 2.63M | -2.38M | -560.00K | |||
| Shares Outstanding | 30.29M | 26.94M | 25.05M | 24.48M | 19.17M | |||
| Tangible Book Value per Share | 0.06 | 0.10 | 0.31 | 0.95 | 2.25 | |||
| Total Shareholders' Equity | 32.68M | 33.92M | 57.80M | 75.28M | 56.92M | |||
| TOTAL LIABILITIES AND EQUITY | 59.96M | 59.99M | 77.81M | 93.65M | 66.96M | |||
| Statistics | ||||||||
| Debt/Equity | 0.45 | 0.36 | 0.11 | 0.01 | 0.04 | |||
| Current Ratio | 1.01 | 1.41 | 2.84 | 4.03 | 8.05 | |||
| Return On Assets (ROA) | -45.92% | -45.30% | -34.13% | -17.84% | -10.96% | |||
| Return On Equity (ROE) | -84.27% | -80.12% | -45.95% | -22.19% | -12.89% | |||
All data in CAD , ROIC based on taxRate of 0.21